H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Does intralymphatic treatment of Hodgkin's disease allow the preservation of fertility? Pregnancy cases

Aleksander Danikiewicz, Małgorzata Muc-Wierzgoń, Peter Hirnle

Med Sci Monit 1996; 2(3): CR314-317

ID: 499813

Published: 1996-05-01


Four young women with diagnosed Hodgkin's disease (stage III b or IV) were treated with standard MOPP/ABVD chemotherapy. After 6 cycles they had residual retroperitoneal changes and to preserve fertility, therapy was subsequently continued as a single intralymphatic injection of 60 mg bleomycin in oily suspension. There were no severe adverse reactions as only transient fever and slight pain in the legs were reported. Follow-up X-rays showed a marked size reduction of retroperitoneal lymph nodes and disappearance of remaining B-symptoms. Each woman became pregnant within 2 to 14 months and gave birth to a healthy infant. Three of the women remain free of disease and one has had a recurrence in the primary site (the neck) and has been treated with second-line intravenous chemotherapy. Intralymphatic treatment of retroperitoneal lymphoma while preserving fertility may produce satisfactory results in selected patients.

Keywords: Hodgkin, treatment, Fertility



Back